Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203


Background: Cyclosporine is a corner stone in organ transplantation, its benefit has been proved for decades. In the long-term therapy, its use is expanded to other clinical conditions despite the lacking profound evidence of its advantage. The aim was to evaluate differences in trough blood levels of cyclosporine in some clinical indications other than transplantation.
Material/Methods: Blood cyclosporine trough levels determined by fluorescent polarization immunoassay (FPIA) TDx Abbott Diagnostics for TDM purpose in one year period was pooled from laboratory data-base. Total of 304 levels from 45 patients (26 males: 19 females) aged 2-62 years, who were on oral cyclosporine daily maintenance dose for conditions like systemic lupus erythematosus (SLE), atopic dermatitis (ADS), idiopathic thrombocytopenic purpura (ITP), dermatopolymyositis (DMS), and cardiomyopathy (CMP) were included.
Results: Cyclosporine trough concentration was undetectable in 27 cases, with maximum1213 μg/L, mode 74 μg/L, median 91 μg/L, mean 104.4±119.5 μg/L SD, and SE 6.85 respectively. Despite poorly defi ned target, most clinicians desired trough concentrations not exceeding 100 μg/L, aiming to reduce toxicity using averagely dose of 200 mg daily. In this respect, nearly 35% were above this point, whereas about 8% were below the detection limit of the method and doing well and no significant difference in concentrations within diagnostic groups except for ADS versus ITP was noted (p

Keywords: Cyclosporine, renal cell carcinoma, gallbladder, metastasis, Organ Transplantation


Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358